In agreement with the idea that p53 has a particular role in the development of SHH-MB, the last is the MB subtype in which p53 mutations are most enriched (21% of tumor samples), with more than half of the patients with SHH/p53 tumors having a germline mutation [172]. The gene discussed is TP53; the disease is neoplasm.